UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
———————
FORM 10-Q
———————
þ |
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
|
|
ACT OF 1934
|
For the quarterly period ended: November 30, 2014
|
or
|
|
|
o |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
|
|
ACT OF 1934
|
For the transition period from: _____________ to _____________
|
Commission File Number: 0-10035
———————
LESCARDEN, INC.
(Exact name of registrant as specified in its charter)
———————
New York
|
13-2538207
|
(State or other jurisdiction
|
(I.R.S. Employer
|
of incorporation or organization)
|
Identification No.)
|
420 Lexington Ave. Ste 212, New York 10170
(Address of Principal Executive Office) (Zip Code)
(212) 687-1050
(Registrant’s telephone number, including area code)
———————
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
|
|
þ
|
Yes
|
o |
No
|
|
|
|
|
|
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).
|
|
o |
Yes
|
o |
No
|
|
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.
|
|
|
Large accelerated filer
|
o |
|
|
Accelerated filer
|
|
|
Non-accelerated filer
|
o |
(Do not check if a smaller
|
|
Smaller reporting company
|
þ
|
|
|
|
reporting company)
|
|
|
|
|
|
|
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
|
|
o |
Yes
|
þ
|
No
|
|
|
Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.
|
|
Class
|
|
Outstanding January 12, 2015
|
Common Stock $.001 par value
|
|
63,622,316
|
TABLE OF CONTENTS
Page
|
PART I – FINANCIAL INFORMATION
|
Item 1. Financial Statements.
|
3 |
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations. |
7
|
Item 3. Quantitative and Qualitative Disclosures About Market Risk. |
8 |
Item 4. Controls and Procedures.
|
8 |
PART II – OTHER INFORMATION
|
Item 1. Legal Proceedings.
|
9 |
Item 1A. Risk Factors.
|
9 |
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.
|
9
|
Item 3. Defaults Upon Senior Securities.
|
9 |
Item 4. Submission of Matters to a Vote of Security Holders.
|
9 |
Item 5. Other Information.
|
9 |
Item 6. Exhibits.
|
9 |
SIGNATURES
|
|
PART I - FINANCIAL INFORMATION
|
Item 1. Financial Statements.
|
LESCARDEN INC.
CONDENSED BALANCE SHEETS
|
|
November 30,
2014
|
|
|
May 31,
2014
|
|
|
|
(UNAUDITED)
|
|
|
(AUDITED)
|
|
ASSETS
|
|
|
|
|
|
|
Current assets:
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
$ |
8,251 |
|
|
$ |
10,432 |
|
Accounts receivable
|
|
|
159,578 |
|
|
|
2,088 |
|
Inventory
|
|
|
88,248 |
|
|
|
113,572 |
|
Total current assets
|
|
|
256,077 |
|
|
|
126,092 |
|
Deferred income tax asset, net of valuation allowance of $1,592,000 and $1,564,000 at November 30, 2014 and May 31, 2014 respectively
|
|
|
–– |
|
|
|
–– |
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
$ |
256,077 |
|
|
$ |
126,092 |
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS' DEFICIT
|
|
|
|
|
|
|
|
|
Current liabilities:
|
|
|
|
|
|
|
|
|
Accounts payable and accrued expenses
|
|
$ |
306,078 |
|
|
$ |
220,592 |
|
Shareholder loan
|
|
|
129,000 |
|
|
|
— |
|
Deferred license fees
|
|
|
1,500 |
|
|
|
4,500 |
|
Total liabilities
|
|
|
436,578 |
|
|
|
225,092 |
|
|
|
|
|
|
|
|
|
|
Stockholders' deficit
|
|
|
|
|
|
|
|
|
Convertible preferred stock - $.02 par value, authorized 2,000,000 shares, issued and outstanding 92,000 shares
|
|
|
1,840 |
|
|
|
1,840 |
|
Common stock - $.001 par value, authorized 200,000,000 shares, 63,622,316 issued and outstanding at November 30, 2014 and May 31, 2014
|
|
|
63,622 |
|
|
|
63,622 |
|
Additional paid-in capital
|
|
|
17,505,936 |
|
|
|
17,505,936 |
|
Accumulated deficit
|
|
|
(17,751,899 |
) |
|
|
(17,670,398 |
) |
Stockholders' deficit
|
|
|
(180,501 |
) |
|
|
(99,000 |
) |
Total liabilities and stockholders' deficit
|
|
$ |
256,077 |
|
|
$ |
126,092 |
|
See notes to financial statements
LESCARDEN INC.
CONDENSED STATEMENTS OF OPERATIONS (UNAUDITED)
|
|
For the three months
Ended November 30,
|
|
|
For the six months
Ended November 30,
|
|
|
|
2014
|
|
|
2013
|
|
|
2014
|
|
|
2013
|
|
Revenues:
|
|
|
|
|
|
|
|
|
|
|
|
|
Product sales
|
|
$ |
165,023 |
|
|
$ |
9,836 |
|
|
$ |
171,270 |
|
|
$ |
317,927 |
|
License fees
|
|
|
1,500 |
|
|
|
1,500 |
|
|
|
3,000 |
|
|
|
3,000 |
|
Total revenues
|
|
|
166,523 |
|
|
|
11,336 |
|
|
|
174,270 |
|
|
|
320,927 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Costs and expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of sales
|
|
|
42,078 |
|
|
|
2,296 |
|
|
|
43,309 |
|
|
|
136,597 |
|
Salaries
|
|
|
13,838 |
|
|
|
27,916 |
|
|
|
41,099 |
|
|
|
57,086 |
|
Professional fees and consulting
|
|
|
24,297 |
|
|
|
19,597 |
|
|
|
60,209 |
|
|
|
49,241 |
|
Rent and office expense
|
|
|
31,187 |
|
|
|
28,502 |
|
|
|
62,400 |
|
|
|
58,650 |
|
Insurance
|
|
|
12,933 |
|
|
|
17,767 |
|
|
|
24,801 |
|
|
|
30,626 |
|
Commission
|
|
|
10,743 |
|
|
|
— |
|
|
|
10,743 |
|
|
|
20,689 |
|
Other administrative expenses
|
|
|
12,464 |
|
|
|
4,693 |
|
|
|
13,210 |
|
|
|
10,108 |
|
Total costs and expenses
|
|
|
147,540 |
|
|
|
100,771 |
|
|
|
255,771 |
|
|
|
362,997 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
$ |
18,983 |
|
|
$ |
(89,435 |
) |
|
$ |
(81,501 |
) |
|
$ |
(42,070 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) per share – basic and diluted
|
|
$ |
0.00 |
|
|
$ |
(0.00 |
) |
|
$ |
(0.00 |
) |
|
$ |
(0.00 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average number of common
shares outstanding – basic and diluted
|
|
|
63,622,316 |
|
|
|
48,722,316 |
|
|
|
63,622,316 |
|
|
|
48,722,316 |
|
See notes to financial statements
LESCARDEN INC.
CONDENSED STATEMENTS OF CASH FLOWS (UNAUDITED)
|
|
For the six months
Ended November 30,
|
|
|
|
2014
|
|
|
2013
|
|
|
|
|
|
|
|
|
Cash flows from operating activities:
|
|
|
|
|
|
|
Net loss
|
|
$ |
(81,501 |
) |
|
$ |
(42,070 |
) |
Adjustments to reconcile net loss to net cash
used in operating activities:
|
|
|
|
|
|
|
|
|
Changes in operating assets and liabilities
|
|
|
|
|
|
|
|
|
(Increase) decrease in accounts receivable
|
|
|
(157,490 |
) |
|
|
25,266 |
|
Decrease in inventory
|
|
|
25,324 |
|
|
|
12,272 |
|
Increase (decrease) in accounts payable and accrued expenses
|
|
|
85,486 |
|
|
|
(53,297 |
) |
Decrease in deferred revenue
|
|
|
— |
|
|
|
(4,782 |
) |
Decrease in deferred license fees
|
|
|
(3,000 |
) |
|
|
(3,000 |
) |
Net cash used in operating activities
|
|
|
(131,181 |
) |
|
|
(65,611 |
) |
|
|
|
|
|
|
|
|
|
Cash flows from investing activities:
|
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
|
|
|
Cash flows from financing activities:
|
|
|
|
|
|
|
|
|
Proceeds from shareholder loan
|
|
|
129,000 |
|
|
|
100,000 |
|
Cash provided by financing activities
|
|
|
129,000 |
|
|
|
100,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Decrease) increase in cash
|
|
|
(2,181 |
) |
|
|
34,389 |
|
|
|
|
|
|
|
|
|
|
Cash - beginning of period
|
|
|
10,432 |
|
|
|
84,562 |
|
|
|
|
|
|
|
|
|
|
Cash – end of period
|
|
$ |
8,251 |
|
|
$ |
118,951 |
|
|
|
|
|
|
|
|
|
|
Supplemental Disclosures of Cash Flow Information |
|
|
|
|
|
|
|
|
Cash paid for interest |
|
$
|
- |
|
|
$
|
- |
|
Cash paid for taxes |
|
$
|
380 |
|
|
$
|
380 |
|
See notes to financial statements
LESCARDEN INC .
(UNAUDITED) NOTES TO FINANCIAL STATEMENTS
November 30, 2014
Note 1 - General:
The accompanying condensed financial statements include all adjustments that are, in the opinion of management, necessary for a fair statement of the results for the interim periods. All such adjustments are of a normal recurring nature. The statements have been prepared in accordance with the requirements for Form 10-Q and, therefore, do not include all disclosures or financial details required by generally accepted accounting principles. These condensed financial statements should be read in conjunction with the financial statements and the notes thereto included in the Company's Annual Report on Form 10-K for the year ended May 31, 2014. The results of operations for the interim periods are not necessarily indicative of results to be expected for a full year's operations.
Note 2 – Going Concern:
The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The financial statements do not include any adjustments relating to the recoverability of assets and the satisfaction of liabilities that might be necessary should the Company be unable to continue as a going concern. As shown in the financial statements, the Company incurred a loss from operations for the six months ended November 30, 2014 of $81,501, has a stockholders’ deficiency of $180,501 and a working capital deficiency of $180,501. These conditions raise substantial doubt about the Company’s ability to continue as a going concern.
The Company’s plan and ability to continue as a going concern is primarily dependent upon its ability to maintain consistent production volumes to fulfill existing sales orders. Alternative sources of supply are being evaluated so that manufacturing and production disruptions can be minimized. There can be no assurance that the Company will be able to establish an alternative source of supply and maintain consistent production volumes to meet demand. The establishment of an alternative source of supply may require additional future expenditures given the uncertainties associated with the regulatory, logistic and financial issues involved but it is likely that testing and regulatory certification will necessitate at least three months before production commences.
At November 30, 2014, inventory of $88,248 consisted of $36,362 of finished goods and $51,886 of raw materials.
Note 4 – Related Party Transactions:
In August 2014, the Company received additional unsecured loans aggregating $129,000 from its Chairman. The loans are interest bearing and due upon demand. Pursuant to an agreement with a director of the Company, sales commission expense of $10,743 for services rendered in connection with the sale of Citrix in Europe was accrued during the three months ended November 30, 2014.
Note 5- Commitments and Contingencies:
At November 30, 2014, the Company is obligated under a non-cancellable lease with an unrelated third party to rent office space which expires on January 31, 2016. The Company is currently negotiating a termination of this lease. At November 30, 2014, the Company has minimum future rental payments due on this lease of $105,161.
There have been no other significant subsequent developments relating to the commitments and contingencies reported on the Company’s latest Annual Report on Form 10-K.
|
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.
|
Results of Operations:
The results of operations for the three and six months ended November 30, 2014 reflect ongoing production disruptions, which has delayed fulfillment of purchase orders to European markets. Preliminary estimates from alternative suppliers of raw material supply indicate significant increases in the unit cost of raw material and there is ongoing uncertainty as to the timing of production capability and fulfillment of outstanding purchase orders.
Three months ended November 30, 2014 compared to November 30, 2013
The Company’s revenues increased in the fiscal quarter ended November 30, 2014 by $155,187 due to the production shipment of Catrix in November 2014. Cost of sales as a percent of sales was 25% for the three months ended November 30, 2014 reflecting lower raw material costs of discounted raw material purchases.
Non-direct costs and expenses during the three months ended November 30, 2014 were 7% higher than those of the comparative prior-year period due to increases in professional fees and commissions of $4,700 and $10,743 offset by decreased salaries and insurance of $14,078 and $4,834 respectively.
Six months ended November 30, 2014 compared to November 30, 2013
The Company’s revenues decreased in the six months ended November 30, 2014 compared to November 30, 2013 by 46% or $146,657 due to the Company’s inability to reestablish production operations. Cost of sales as a percent of sales decreased from 43% for the six months ended November 30, 2013 to 25% reflecting the one-time acquisition of discounted raw material that decreased raw material cost.
Non-direct costs and expenses during the six months ended August 31, 2014 were 6% lower than those of the comparative prior-year period.
Liquidity and Capital Resources
As of November 30, 2014, the Company’s liabilities exceeded its assets by $180,501. The Company’s cash and cash equivalents balance decreased by $2,181 in the six months ended November 30, 2014 to $8,251.
The Company has no material commitments for capital expenditures at November 30, 2014.
|
Item 3. Quantitative and Qualitative Disclosures About Market Risk.
|
Not required for smaller reporting company.
|
Item 4. Controls and Procedures.
|
The Company maintains disclosure controls and procedures that are designed to ensure that information required to be disclosed in the Company’s filings under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the periods specified in the rules and forms of the Securities and Exchange Commission. Such information is accumulated and communicated to the Company’s management, including its Chief Executive and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. The Company’s management, including the Chief Executive and Chief Financial Officer, recognizes that any set of controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives.
The Company has carried out an evaluation, under the supervision and with the participation of the Company’s management, including the Company’s Chief Executive and Chief Financial Officer, of the effectiveness of the design and operation of the Company’s disclosure controls and procedures. Based on such evaluation, the Company’s Chief Executive and Chief Financial Officer concluded that the Company’s disclosure controls and procedures are effective as of the end of the period covered by this quarterly report on Form 10-Q.
There have been no significant changes in the Company’s internal controls or in other factors that could significantly affect the internal controls subsequent to the date of their evaluation in connection with the preparation of this quarterly report on Form 10-Q.
PART II - OTHER INFORMATION
|
Item 1. Legal Proceedings.
|
None.
None.
|
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.
|
None
|
Item 3. Defaults Upon Senior Securities.
|
None.
|
Item 4. Submission of Matters to a Vote of Security Holders.
|
None.
|
Item 5. Other Information.
|
None.
Exhibit No.
|
|
Description
|
|
|
Certification pursuant to Exchange Act Rule 13a – 14 (a)/15d-14(a)
|
|
|
Certification pursuant to 18 U.S.C. Section 1350 as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
LESCARDEN INC.
|
|
|
(Registrant)
|
|
|
|
|
|
Date: January 12, 2015
|
By:
|
/s/ William E. Luther |
|
|
|
William E. Luther
|
|
|
|
Chief Executive and Chief Financial Officer |
|
|
|
|
|
Exhibit 31
CERTIFICATION
I, William E. Luther, certify that:
1. I have reviewed this quarterly report on Form 10-Q of Lescarden Inc.;
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
|
a)
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
|
b)
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
|
c)
|
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of end of the period covered by this report based on such evaluation; and
|
|
d)
|
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
|
5.
|
The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent function):
|
|
a)
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
|
|
b)
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
|
|
|
|
|
|
|
|
|
By:
|
/s/ William E. Luther |
|
|
|
William E. Luther
|
|
|
|
Chief Executive and Chief Financial Officer
|
|
|
|
|
|
EXHIBIT 32
CERTIFICATION PURSUANT TO
18 U.S.C SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the quarterly report of Lescarden Inc. (the "Company") on Form 10Q for the period ended November 30, 2014 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, William E. Luther, Chief Executive and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. section 1350, as adopted pursuant to section 906 of Sarbanes-Oxley Act of 2002, that to the best of my knowledge:
|
1.
|
The Report fully complies with the requirements of section 13 (a) or 15 (d) of the Securities Exchange Act of 1934, and
|
|
2.
|
The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.
|
|
|
|
|
|
|
|
|
By:
|
/s/ William E. Luther |
|
|
|
William E. Luther
|
|
|
|
Chief Executive and Chief Financial Officer
|
|
|
|
|
|
Lescarden (CE) (USOTC:LCAR)
Historical Stock Chart
Von Mai 2024 bis Jun 2024
Lescarden (CE) (USOTC:LCAR)
Historical Stock Chart
Von Jun 2023 bis Jun 2024